[go: up one dir, main page]

MXPA03009604A - Compuestos de espiropirazol. - Google Patents

Compuestos de espiropirazol.

Info

Publication number
MXPA03009604A
MXPA03009604A MXPA03009604A MXPA03009604A MXPA03009604A MX PA03009604 A MXPA03009604 A MX PA03009604A MX PA03009604 A MXPA03009604 A MX PA03009604A MX PA03009604 A MXPA03009604 A MX PA03009604A MX PA03009604 A MXPA03009604 A MX PA03009604A
Authority
MX
Mexico
Prior art keywords
spiropyrazole
compounds
spiropyrazole compounds
compound
formula
Prior art date
Application number
MXPA03009604A
Other languages
English (en)
Inventor
Gharagozloo Parviz
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MXPA03009604A publication Critical patent/MXPA03009604A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Un compuesto de la formula (I) en donde, Z, W,. A, B, C, R1, R2, Q y n son lo que se revela en el presente.(Ver Formula).
MXPA03009604A 2001-04-18 2002-04-18 Compuestos de espiropirazol. MXPA03009604A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28467501P 2001-04-18 2001-04-18
PCT/US2002/012376 WO2002085355A1 (en) 2001-04-18 2002-04-18 Spiropyrazole compounds

Publications (1)

Publication Number Publication Date
MXPA03009604A true MXPA03009604A (es) 2004-04-02

Family

ID=23091099

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009604A MXPA03009604A (es) 2001-04-18 2002-04-18 Compuestos de espiropirazol.

Country Status (27)

Country Link
US (2) US6635653B2 (es)
EP (1) EP1385515B1 (es)
JP (1) JP4342181B2 (es)
KR (1) KR100628292B1 (es)
CN (1) CN1516584A (es)
AT (1) ATE403429T1 (es)
AU (1) AU2002311833B2 (es)
BR (1) BR0209127A (es)
CA (1) CA2444634C (es)
CY (1) CY1108454T1 (es)
CZ (1) CZ20032849A3 (es)
DE (1) DE60228071D1 (es)
DK (1) DK1385515T3 (es)
ES (1) ES2312584T3 (es)
HU (1) HUP0401333A3 (es)
IL (2) IL158485A0 (es)
MX (1) MXPA03009604A (es)
NO (1) NO20034660L (es)
NZ (1) NZ528978A (es)
PL (1) PL367263A1 (es)
PT (1) PT1385515E (es)
RU (1) RU2299883C2 (es)
SI (1) SI1385515T1 (es)
UA (1) UA74439C2 (es)
WO (1) WO2002085355A1 (es)
YU (1) YU82403A (es)
ZA (1) ZA200308103B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1516584A (zh) * 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物
DK1491212T3 (da) 2002-03-29 2012-10-29 Mitsubishi Tanabe Pharma Corp Middel til behandling af søvnforstyrrelser
EP1601674B1 (en) 2002-09-09 2012-08-08 Janssen Pharmaceutica NV Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
US20110092704A1 (en) * 2002-10-17 2011-04-21 Parvis Gharagozloo Preparation of triazospiro compounds
US20040242583A1 (en) * 2003-01-20 2004-12-02 Aventis Pharma Deutschland Gmbh Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
WO2004103305A2 (en) * 2003-05-16 2004-12-02 Euroceltique S.A. Spiropyrazole compound
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
CA2561513C (en) 2004-03-29 2019-02-26 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
DE602006016244D1 (de) 2005-03-08 2010-09-30 Janssen Pharmaceutica Nv Diazaspiro-ä4,4ü-nonanderivate als neurokinin-(nk1)-antagonisten
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
CN101622254B (zh) 2006-11-28 2013-05-29 詹森药业有限公司 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
CN101595100B (zh) 2007-01-16 2014-06-11 普渡制药公司 作为orl-1配体的杂环取代的哌啶
CN101679430B (zh) 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
EP3564240B1 (en) 2007-08-31 2022-04-06 Purdue Pharma L.P. Piperidine intermediates
WO2010010458A1 (en) 2008-07-21 2010-01-28 Purdue Pharma L.P. Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
UA107943C2 (xx) * 2009-11-16 2015-03-10 Lilly Co Eli Сполуки спіропіперидину як антагоністи рецептора orl-1
ES2613631T3 (es) 2010-12-22 2017-05-25 Purdue Pharma L.P. Compuestos de piperidina de tipo quinoxalina sustituidos con fósforo y usos de los mismos
US9290488B2 (en) 2011-12-01 2016-03-22 Purdue Pharma L.P. Azetidine-substituted quinoxalines as opioid receptor like-1 modulators
US9085561B2 (en) 2012-07-30 2015-07-21 Purdue Pharma L.P. Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
SI3490560T1 (sl) 2016-07-29 2025-04-30 Janssen Pharmaceutica, N.V. Niraparib za uporabo pri metodi zdravljenja raka prostate
CN111825681A (zh) * 2020-07-07 2020-10-27 扬州大学 一种合成(e)-亚苄基螺吡唑吡咯嗪酮类化合物的方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157497A (es) *
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
US3325499A (en) 1964-11-02 1967-06-13 Mcneilab Inc 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3923993A (en) * 1973-06-28 1975-12-02 American Home Prod Process for treating neuroendocrinopathic diseases employing fluspirilene
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
JPS60120872A (ja) 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
WO1995028397A1 (en) 1994-04-14 1995-10-26 Merck & Co., Inc. Alpha1c adrenergic receptor antagonists
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
FR2725206B1 (fr) * 1994-09-29 1996-12-06 Roussel Uclaf Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
WO1997010213A1 (en) 1995-09-13 1997-03-20 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidine derivatives
AU2388697A (en) 1996-04-19 1997-11-12 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
US6063796A (en) 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists
JP4366532B2 (ja) 1997-05-30 2009-11-18 萬有製薬株式会社 ２−オキソイミダゾール誘導体
JPH10330377A (ja) 1997-06-02 1998-12-15 Kyowa Hakko Kogyo Co Ltd ピペリジン誘導体
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP0921125B1 (en) 1997-12-05 2002-01-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro[4,5]decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
ATE219772T1 (de) 1998-01-19 2002-07-15 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste
AU754716B2 (en) 1998-03-26 2002-11-21 Japan Tobacco Inc. Amide derivatives and nociceptin antagonists
AU3809999A (en) * 1998-05-18 1999-12-06 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ID29137A (id) 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
CZ2003635A3 (cs) 2000-09-06 2004-12-15 Ortho Mcneil Pharmaceutical, Inc. Substituovaný pyrazol a jeho použití
CN1516584A (zh) * 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物

Also Published As

Publication number Publication date
HK1062885A1 (en) 2004-12-03
PL367263A1 (en) 2005-02-21
EP1385515A1 (en) 2004-02-04
RU2299883C2 (ru) 2007-05-27
HUP0401333A2 (hu) 2004-10-28
US20030027834A1 (en) 2003-02-06
CN1516584A (zh) 2004-07-28
RU2003133455A (ru) 2005-05-10
NO20034660D0 (no) 2003-10-17
EP1385515A4 (en) 2004-06-30
YU82403A (sh) 2006-08-17
CA2444634C (en) 2011-06-07
UA74439C2 (uk) 2005-12-15
US20040087641A1 (en) 2004-05-06
KR100628292B1 (ko) 2006-09-27
ATE403429T1 (de) 2008-08-15
US6635653B2 (en) 2003-10-21
SI1385515T1 (sl) 2008-12-31
CY1108454T1 (el) 2014-04-09
JP2004531531A (ja) 2004-10-14
CZ20032849A3 (en) 2004-03-17
NZ528978A (en) 2004-06-25
PT1385515E (pt) 2008-09-15
KR20040008159A (ko) 2004-01-28
CA2444634A1 (en) 2002-10-31
DE60228071D1 (de) 2008-09-18
DK1385515T3 (da) 2008-10-27
JP4342181B2 (ja) 2009-10-14
HUP0401333A3 (en) 2004-11-29
NO20034660L (no) 2003-12-17
IL158485A0 (en) 2004-05-12
ES2312584T3 (es) 2009-03-01
BR0209127A (pt) 2006-03-21
WO2002085355A1 (en) 2002-10-31
EP1385515B1 (en) 2008-08-06
IL158485A (en) 2009-09-01
ZA200308103B (en) 2004-10-18
AU2002311833B2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
YU82403A (sh) Jedinjenja spiropirazola
MXPA03009600A (es) Analogos de nociceptina.
DE60214591D1 (en) Pyrazolpyrimidinfungizide
DK1385514T5 (da) Spiroinden- og spiroindanforbindelser
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2002072506A3 (en) 7-pyrollyl tetracycline compounds and methods of use thereof
GB0124627D0 (en) Novel compounds
PL369530A1 (en) Chemical compounds
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA05002307A (es) Composiciones antimicrobianas.
MXPA03009602A (es) Analogos de nociceptina.
MY122829A (en) Linezolid-crystal form ii
SE0004245D0 (sv) Novel compounds and their use
PT1975164E (pt) Compostos de octa-hidrobenzimidazolona utilizados como analgésicos
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
ATE431328T1 (de) Photopolymerisierbare verbindungen
MXPA05003881A (es) Preparacion de compuestos triazospiro.
TW200420552A (en) Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture
AU4865201A (en) An intermediate and process for its synthesis

Legal Events

Date Code Title Description
FG Grant or registration